More in‐depth mechanistic research is required in the future to further explore these dimensions, thereby deepening our understanding of immune regulatory mechanisms within the tumor microenvironment and ultimately validating the therapeutic potential of CD74+ B cells in PSCC. Here, CD74 is linked to neoplasm.